AKT1 and cancer: Our data showed that NC exhibited a dose-dependent inhibition in PI3K/Akt pathway, as evidenced by decreased phosphorylation of PI3K and AKT, in line with the earlier findings that NC regulated PI3K/Akt pathway in different types of cancer cells [32].